COM-503
- Generic Name
- COM-503
A Clinical Trial to Assess COM503 in Participants with Advanced Solid Malignancies
Phase 1
Recruiting
- Conditions
- NeoplasmCancer, Malignant Tumors
- Interventions
- First Posted Date
- 2025-01-06
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Compugen Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT06759649
- Locations
- 🇺🇸
START Midwest, Grand Rapids, Michigan, United States
🇺🇸NEXT Oncology San Antonio, San Antonio, Texas, United States
🇺🇸START, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath